Novel platinum(II) derivatives of analogues of netropsin and distamycin: Synthesis, DNA binding and cytotoxic properties

Medicinal Chemistry Research

Volumn 6, Issue 6, 1996, Pages 365-371

  Lee, Moses ^a   Simpson Jr , Jacob E ^a   Burns, A J ^a   Kupchinsky, S ^a   Brooks, Natalie ^b   Hartley, John A ^b   Kelland, Lloyd R ^c  

^a FURMAN UNIVERSITY   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001614181     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. (a) Chabner, B. A.; Collins, J. M. In Cancer Chemotherapy: Principles and Practice, Chabner, B. A.; Collins, J. A., Eds; J. B. Lippincott Co.: New York; 1990; p 471.
2. (b) Kelland, L. R. Critical Reviews in Oncology/Hematology 1993, 15, 191-219.
3. (c) McKeage, M.J.; Kelland, L.R. In Molecular Aspects of Anticancer Drugs-DNA Interactions, Vol. 1; Neidle, S.; Waring, M. Eds.; CRC Press, Boca Raton, 1993; p 169.
4. (d) Pratt, W. B.; Ruddon, R. W.; Ensminger, W. D.; Maybaum, J. The Anticancer Drugs, Second Edition; Oxford University Press; New York; 1994.
5. Harrap, K. R. Cancer Treat. Rev. 1985, 12 (Suppl. A), 21.
6. Kelland, L. R.; Abel, G.; McKeage, M. J.; Jones, M.; Goddard, P. M.; Murrer, B. A.; Harrap, K. R. Cancer Res. 1993, 53, 2581.
7. (a) Comess, M. K.; Lippard, S. J. In Molecular Aspects of Anticancer Drug-DNA Interactions, Vol. 1; Neidle, S.; Waring, M. Eds.; The Macmillan Press, Ltd.; London; 1993; p 134.
8. (b) Lemaire, M. A.; Schwartz, A.; Rahmouni, A. R.; Leng, M. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 1982.
9. Lee, H. H.; Palmer, B. D.; Baguley, B. C.; Chin, M.; McFayden, W. D.; Wickham, G.; Thorsbourne-Palmer, D.; Wakelin, L. P. G.; Denny, W. A. J. Med. Chem, 1992, 35, 2983.
10. Zimmer, C.; Wahnert, U. Prog. Biophys. Mol. Biol. 1986, 47, 31-112.
11. Wyatt, M. D.; Garbiras, B. J.; Haskell, M. K.; Lee, M.; Souhami, R. L.; Hartley, J. A. Anti-Cancer Drug Des. 1994, 9, 511.
12. Jones, R. C. F.; Ward, G. J. Tetrahedron Lett. 1988, 29, 3853.
13. The syntheses of compounds 8 and 9 will be reported elsewhere.
14. Hartwig, J. F.; Pu, P. M.; Lippard, S. J. J. Am. Chem. Soc. 1992, 114, 8292.
15. Morgan, A.R.; Lee, J.S.; Pulleybank, D.F.; Murray, N.L.; Evans, D.H. Nucl. Acids Res. 1979, 7, 547.
16. Lown, J.W. Acc. Chem. Res. 1982, 15, 381.
17. Arcamone, R. M.; Animati, R.; Barbieri, B.; Configliacchi, E.; D'Alessio, R.; Geroni, C.; Giuliani, F. C.; Lazzari, E.; Menozzi, M.; Mongelli, N.; Penco, S.; Verini, M. A. J. Med. Chem. 1989, 32, 774.
18. Kelland, L.R..; Barnard, C.F.J.; Mellish, K.J.; Jones, M.; Goddard, P.M.; Valenti, M.; Bryant, A.; Murrer, B.A.,; Harrap, K.R. Cancer Res. 1994, 54, 5618.
19. Johnson, S.W.; Perez, R.P.; Godwin, A.K.; Yeung, A.T.; Handel, L.M.; Ozols, R.F.; Hamilton, T.C. Biochem. Pharmacol. 1994, 47, 687.
20. Carmichael, J.; DeGraff, W. G.; Gazdar, A. F.; Minna, J. D.; Mitchell, J. B. Cancer Res. 1987, 47, 936.